Search research articles
Contact Us
Filters
Showing results (51-60 of 297) with videos related to
Page
of 30
Sort By:
JCO Clinical Cancer Informatics
|
March 9, 2026
Leveraging Artificial Intelligence for Immune Checkpoint Inhibitor Safety: A Scoping Review of Current Applications
Chin Hang Yiu, Edward C Y Lau, Charlotte Thuy Tien Le, et al.
Scientific Reports
|
January 16, 2021
Combination of absolute pitch and tone language experience enhances lexical tone perception
Akshay R Maggu, Joseph C Y Lau, Mary M Y Waye, et al.
Journal of Bacteriology
|
September 1, 2009
Differential lipopolysaccharide core capping leads to quantitative and correlated modifications of mechanical and structural properties in Pseudomonas aeruginosa biofilms
Peter C Y Lau, Theresa Lindhout, Terry J Beveridge, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1994
Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A
L Zhou, D Ritchie, E Y Wang, et al.
The Journal of Rheumatology
|
December 1, 1986
Lymphocytotoxins in vasculitis. Correlation with clinical manifestations and laboratory variables
W Pruzanski, D Sarraf, M Klein, et al.
Environmental Microbiome
|
April 27, 2021
Genome-centric resolution of novel microbial lineages in an excavated Centrosaurus dinosaur fossil bone from the Late Cretaceous of North America
Renxing Liang, Maggie C Y Lau, Evan T Saitta, et al.
Transplantation
|
August 27, 1995
Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection
W P Fung-Leung, B L Pope, E Chourmouzis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1985
Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line
C Y Lau, E Y Wang, D Li, et al.
The Journal of Biological Chemistry
|
June 9, 1995
Tepoxalin, a novel dual inhibitor of the prostaglandin-H synthase cyclooxygenase and peroxidase activities
S S Tam, D H Lee, E Y Wang, et al.
Journal of the American College of Cardiology
|
November 17, 2018
Reply: Sex-Based Differences in Outcomes of Oral Anticoagulation: Does Antiplatelet Therapy Matter?
Sharon W Y Law, Wallis C Y Lau, Ian C K Wong, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 297) with videos related to
Sort By:
Page
of 30
JCO Clinical Cancer Informatics
|
March 9, 2026
Leveraging Artificial Intelligence for Immune Checkpoint Inhibitor Safety: A Scoping Review of Current Applications
Chin Hang Yiu, Edward C Y Lau, Charlotte Thuy Tien Le, et al.
Scientific Reports
|
January 16, 2021
Combination of absolute pitch and tone language experience enhances lexical tone perception
Akshay R Maggu, Joseph C Y Lau, Mary M Y Waye, et al.
Journal of Bacteriology
|
September 1, 2009
Differential lipopolysaccharide core capping leads to quantitative and correlated modifications of mechanical and structural properties in Pseudomonas aeruginosa biofilms
Peter C Y Lau, Theresa Lindhout, Terry J Beveridge, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1994
Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A
L Zhou, D Ritchie, E Y Wang, et al.
The Journal of Rheumatology
|
December 1, 1986
Lymphocytotoxins in vasculitis. Correlation with clinical manifestations and laboratory variables
W Pruzanski, D Sarraf, M Klein, et al.
Environmental Microbiome
|
April 27, 2021
Genome-centric resolution of novel microbial lineages in an excavated Centrosaurus dinosaur fossil bone from the Late Cretaceous of North America
Renxing Liang, Maggie C Y Lau, Evan T Saitta, et al.
Transplantation
|
August 27, 1995
Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection
W P Fung-Leung, B L Pope, E Chourmouzis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1985
Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line
C Y Lau, E Y Wang, D Li, et al.
The Journal of Biological Chemistry
|
June 9, 1995
Tepoxalin, a novel dual inhibitor of the prostaglandin-H synthase cyclooxygenase and peroxidase activities
S S Tam, D H Lee, E Y Wang, et al.
Journal of the American College of Cardiology
|
November 17, 2018
Reply: Sex-Based Differences in Outcomes of Oral Anticoagulation: Does Antiplatelet Therapy Matter?
Sharon W Y Law, Wallis C Y Lau, Ian C K Wong, et al.
Page
of 30